Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityNon-Current AssetsOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GeoVax Labs (GOVX) Shares Outstanding (2016 - 2025)

GeoVax Labs (GOVX) has disclosed Shares Outstanding for 16 consecutive years, with $29.7 million as the latest value for Q3 2025.

  • On a quarterly basis, Shares Outstanding rose 245.04% to $29.7 million in Q3 2025 year-over-year; TTM through Sep 2025 was $29.7 million, a 245.04% increase, with the full-year FY2024 number at $10.5 million, up 432.93% from a year prior.
  • Shares Outstanding was $29.7 million for Q3 2025 at GeoVax Labs, up from $15.9 million in the prior quarter.
  • In the past five years, Shares Outstanding ranged from a high of $29.7 million in Q3 2025 to a low of $100.0 in Q1 2021.
  • A 5-year average of $9.7 million and a median of $6.4 million in 2021 define the central range for Shares Outstanding.
  • Peak YoY movement for Shares Outstanding: skyrocketed 1581825.5% in 2021, then crashed 93.24% in 2023.
  • GeoVax Labs' Shares Outstanding stood at $425436.0 in 2021, then soared by 312.67% to $1.8 million in 2022, then increased by 12.62% to $2.0 million in 2023, then surged by 432.93% to $10.5 million in 2024, then surged by 181.92% to $29.7 million in 2025.
  • Per Business Quant, the three most recent readings for GOVX's Shares Outstanding are $29.7 million (Q3 2025), $15.9 million (Q2 2025), and $13.8 million (Q1 2025).